← REGULATORY CHANGES
FEDERAL REGISTER · NOTICEAugust 9, 2024NOTICE — NO LEGAL EFFECT

Animal Food Ingredient Consultation; Draft Guidance for Industry; Availability

What this record is not

Document details are published in the U.S. Federal Register; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA or the Office of the Federal Register. The authoritative text is on federalregister.gov.

STATUSNOTICE — NO LEGAL EFFECT
EFFECTIVE—
COMMENTS CLOSESep 9, 2024 · closed
APPLIES TO · SPEQ TAGFoodVeterinary
Document type
Notice
Agency
Health and Human Services Department
Published
August 9, 2024
Comments close
September 9, 2024
Document number
2024-17778
Docket
FDA-2024-D-2978
ABSTRACT

The Food and Drug Administration (FDA or Agency) is announcing the availability of draft guidance for industry #294 entitled "Animal Food Ingredient Consultation (AFIC)." This draft guidance describes FDA's interim AFIC process and explains one way FDA intends to work with firms that are developing animal food ingredients after the Memorandum of Understanding (MOU) with the Association of American Feed Control Officials (AAFCO) expires on October 1, 2024, and while FDA evaluates the animal Food Additive Petition and generally recognized as safe (GRAS) Notification programs. The new AFIC process will provide an additional way for engagement with FDA regarding ingredients for which firms may otherwise have used the AAFCO ingredient definition process. AFIC will help FDA identify any potential safety concerns associated with such ingredients. The AFIC process will also allow for public awareness of and input on such ingredients. In addition, this draft guidance describes FDA's enforcement policy for certain ingredients assessed using the AFIC process.

Abstract as published in the Federal Register.

READ THE FULL DOCUMENT

The complete document — every provision, the docket, and the comment instructions — is published in the Federal Register. SPEQ surfaces and indexes it for reference; the authoritative text lives on federalregister.gov.

View on federalregister.gov →

That is what FDA published. A free account files it on your watchlist and sends one weekly email with whatever lands next.

Create a free account